What makes them both great will keep them great for years to come.
What does this important collaboration mean for biosimilars?
Are T-Mobile and Sprint the next hottest couple in wireless?
But what about the spectrum deal?
What does new leadership mean for Vertex's future?
Many investors wrote off Affymax in June 2010, but was that premature?
Pfizer is making a new bet on a new drug to fight excessive scarring.
The company can begin selling Eylea, which treats the leading cause of blindness in the elderly.
Looks like Amazon.com's pugnacious bet on national sales tax reform is paying off.
Celgene strikes an unusual agreement.
An unprecedented cancer drug development deal.
Shares plummet as Sprint unveils plans that don't include the WiMax provider.
Steve Jobs' real legacy.
Merck readies itself to enter this potential new market.
Is this the iPad killer after all?
Turning the social network inside out.
Orexigen has new life.
This has been the month of the handset. How will this ecosystem change in the next 12 months?
Who will come out ahead?